companydata.dkcompanydata.dk

APGAR DANMARK A/S: Financial statements 2025

CVR: 17533533

Source: annual report 2025, Danish Business Authority

01/07/2024 – 30/06/2025

APGAR DANMARK A/S (CVR 17533533) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 12,125,986 and a net result of DKK -1,991,044 compared with DKK 21,676 the year before. That is a decrease of 5.8% compared with the year before. Equity in the 2025 report amounted to DKK 10,236,447. The solvency ratio was 66.7%. The company had 10 employees in the financial year.

Gross Profit
DKK 12,125,986
Profit/Loss
DKK -1,991,044
Equity
DKK 10,236,447
Total Assets
DKK 15,349,550
Employees
10

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-12.1 mio.-2 mio.10.2 mio.10
2024-12.9 mio.22 t.12.2 mio.10
2023-14.6 mio.1.5 mio.12.5 mio.9
2022-12.3 mio.853 t.11.2 mio.8
2021-11.8 mio.867 t.13.4 mio.8

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is APGAR DANMARK A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About APGAR DANMARK A/S

APGAR DANMARK A/S is a Danish company of the type Aktieselskab based in Brøndby, founded in 1993. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Christian Markussen and Stig Pieler. The board consists of Christian Markussen, Hanne Pieler, Jan Pedersen and Mette Markussen. The company is owned by PIELER GROUP A/S and MARKUSSEN MEDICAL HOLDING ApS. The company has 13 employees (2018). In 2025, the company reported a gross profit of DKK 12,125,986 and a net result of DKK -1,991,044 compared with DKK 21,676 the year before. Equity in the 2025 report amounted to DKK 10,236,447.

Source: annual report 2025, Danish Business Authority